Clinical Trial Detail

NCT ID NCT04115306
Title Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phoenix Molecular Designs
Indications

triple-receptor negative breast cancer

breast cancer

Therapies

PMD-026

Age Groups: senior adult

No variant requirements are available.